Integrated genomics-based discovery of new druggable kinases as a therapeutic target and cancer biomarker for lung cancer.

被引：0
|
作者：
Daigo, Yataro
Takano, Atsushi
Nakamura, Yusuke
机构：
[1] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan
[2] Shiga Univ Med Sci, Can Ctr, Otsu, Shiga, Japan
[3] Univ Tokyo, Inst Med Sci, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e23144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23144
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Characterization of LASEP3 as a serological and prognostic biomarker and a therapeutic target for lung cancer.
    Takano, Atsushi
    Nakamura, Yusuke
    Daigo, Yataro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
    Yang, Wanjuan
    Soares, Jorge
    Greninger, Patricia
    Edelman, Elena J.
    Lightfoot, Howard
    Forbes, Simon
    Bindal, Nidhi
    Beare, Dave
    Smith, James A.
    Thompson, I. Richard
    Ramaswamy, Sridhar
    Futreal, P. Andrew
    Haber, Daniel A.
    Stratton, Michael R.
    Benes, Cyril
    McDermott, Ultan
    Garnett, Mathew J.
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D955 - D961
  • [23] SGDriver: a novel structural genomics-based approach to prioritize cancer related and potentially druggable somatic mutations
    Junfei Zhao
    Feixiong Cheng
    Zhongming Zhao
    BMC Bioinformatics, 16
  • [24] New technologies in cancer. Protein microarrays for biomarker discovery
    Matarraz, Sergio
    Gonzalez-Gonzalez, Maria
    Jara, Maria
    Orfao, Alberto
    Fuentes, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (03): : 156 - 161
  • [25] New approaches for biomarker discovery in lung cancer
    Valle, RPC
    Chavany, C
    Zhukov, TA
    Jendoubi, M
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (01) : 55 - 67
  • [26] New technologies in cancer. Protein microarrays for biomarker discovery
    Sergio Matarraz
    María González-González
    María Jara
    Alberto Orfao
    Manuel Fuentes
    Clinical and Translational Oncology, 2011, 13 : 156 - 161
  • [27] SGDriver: a novel structural genomics-based approach to prioritize cancer related and potentially druggable somatic mutations
    Zhao, Junfei
    Cheng, Feixiong
    Zhao, Zhongming
    BMC BIOINFORMATICS, 2015, 16
  • [28] Identification of a novel oncogenic receptor tyrosine kinase ELSERT as a new biomarker and a druggable target for lung and esophageal cancer
    Daigo, Yataro
    Nishino, Ryohei
    Takano, Atsushi
    Tsuchiya, Eiju
    Nakamura, Yusuke
    CANCER RESEARCH, 2009, 69
  • [29] Characterization of URST1 as a biomarker and therapeutic target for oral cancer.
    Takano, Atsushi
    Yoshitake, Yoshihiro
    Shinohara, Masanori
    Daigo, Yataro
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18092 - E18092
  • [30] Characterization of OASEP1 as a biomarker and therapeutic target for oral cancer.
    Takano, Atsushi
    Yoshitake, Yoshihiro
    Shinohara, Masanori
    Daigo, Yataro
    CANCER RESEARCH, 2022, 82 (12)
12345